Skip to content

Clinical trials

Leukemia, Mast-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20031
20042
20054
20063
20073
20085
20096
20102
20112
20132
20141
20153
20161
20181
20191
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated7
Active, not recruiting3
Recruiting3
Available1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center6
Blueprint Medicines Corporation5
Wake Forest University Health Sciences4
Jason Robert Gotlib3
National Cancer Institute (NCI)3
UNC Lineberger Comprehensive Cancer Center3
Case Comprehensive Cancer Center2
City of Hope Medical Center2
Cogent Biosciences, Inc.2
M.D. Anderson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Mast-Cell48
Leukemia, Biphenotypic, Acute31
Precursor Cell Lymphoblastic Leukemia-Lymphoma31
Leukemia, Lymphocytic, Chronic, B-Cell29
Burkitt Lymphoma27
Leukemia, Hairy Cell27
Leukemia, Large Granular Lymphocytic27
Leukemia, Myeloid, Acute26
Leukemia, Myelomonocytic, Chronic25
Lymphoma, Large B-Cell, Diffuse25

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.